Found 8 matching trials
Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
PHASE3The purpose of this study is to evaluate the platelet count change from bas...
Location
Omeros Investigational Site
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
PHASE3The primary objective of this study is to evaluate the effect of OMS721 on ...
Location
Omeros Investigational Site
Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
PHASE2The purpose of this study is to assess the safety, efficacy, pharmacokineti...
Location
Omeros Investigational Site
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
PHASE2The goal of this project is to rapidly screen promising agents, in the sett...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
PHASE2The purpose of this study is to evaluate the safety and efficacy of narsopl...
Location
Omeros Investigational Site
OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy
N/AThe purpose of this compassionate use study, for two patients with thrombot...
Location
Multiple Locations
Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab
N/AThe purpose of the EAP is to provide access to hematopoietic stem cell tran...
Status
Approved For Marketing
Location
Multiple Locations
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
PHASE2The purpose of this study was to evaluate the safety and tolerability of OM...
Location
Omeros Investigational Site